의약품 관련 법령
BfArM: Information Note on the Electronic Declaration of Marketed Medicinal Products Not Requiring Marketing Authorization
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-12-07 | 조회수 | 1,129 |
| 국가정보 | 유럽>독일 | ||
| 출처 | BfArM | ||
| 원문 | www.bfarm.de | ||
| 첨부파일 | |||
BfArM_ Information Note on the Electronic Declaration of Marketed Medicinal Products Not Requiring Marketing Authorization.pdf(118.03KB)The BfArM wishes to inform that from 02-Feb-2012, notifications of marketed medicinal products not requiring Marketing Authorization to § 67 (5) of the Drug Law, as well as notifications of variations and termination of the placing on the market of such medicinal products shall be made exclusively using the online application “Electronic Standard Approvals” available through the web portal PharmNe...
- 이전글 Resolution RDC 253: Amends Resolution RDC 20/2013 on the Electronic Submission Procedure Applied to the Marketing Authorization of New Medicinal Products
- 다음글 PEI Information Note: Requirements in Accordance with the Falsified Medicines Directive (Directive 2011/62/EC)
